Macrogenics (MGNX)
3.95
+0.04 (1.02%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G MACROGENICS INC Filed by: MILLENNIUM MANAGEMENT LLC
June 5, 2026 5:04 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: O'Brien Federica F.
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: Jackson Scott Thomas
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: HEIDEN WILLIAM K
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: SIEGEL JAY PHILIP
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: Liu Margaret
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: Chhabra Meenu
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: HURWITZ EDWARD
May 20, 2026 4:14 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: STUMP DAVID C
May 20, 2026 4:13 PM - SEC Filing
Form 4 MACROGENICS INC For: May 19 Filed by: Koenig Scott
May 20, 2026 4:13 PM - SEC Filing
Form 4 MACROGENICS INC For: May 18 Filed by: Ferrante Karen Jean
May 20, 2026 4:13 PM - SEC Filing
Form 8-K MACROGENICS INC For: May 19
May 20, 2026 4:01 PM - SEC Filing
Form SCHEDULE 13G/A MACROGENICS INC Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:30 AM - SEC Filing
Form SCHEDULE 13G MACROGENICS INC Filed by: MILLENNIUM MANAGEMENT LLC
May 14, 2026 5:50 PM - SEC Filing
Form SCHEDULE 13G MACROGENICS INC Filed by: BANK OF AMERICA CORP /DE/
May 14, 2026 5:25 PM - SEC Filing
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
May 14, 2026 4:01 PM - StreetInsider
Form 8-K MACROGENICS INC For: May 13
May 13, 2026 4:23 PM - SEC Filing
Form 10-Q MACROGENICS INC For: Mar 31
May 13, 2026 4:14 PM - SEC Filing
Macrogenics (MGNX) Misses Q1 EPS by 1c
May 13, 2026 4:03 PM - StreetInsider
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
May 13, 2026 4:01 PM - Globe NewsWire
Form 8-K MACROGENICS INC For: May 11
May 12, 2026 8:00 AM - SEC Filing
MacroGenics to sell manufacturing operations to Bora for $122.5 million
May 11, 2026 5:22 PM - StreetInsider
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
May 11, 2026 5:20 PM - Globe NewsWire
Macrogenics (MGNX) Halted, News Pending
May 11, 2026 4:25 PM - StreetInsider
Form 8-K MACROGENICS INC For: May 01
May 4, 2026 4:02 PM - SEC Filing
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
May 4, 2026 7:35 AM - StreetInsider
MacroGenics expands ZYNYZ royalty deal with Sagard for $60 million
May 4, 2026 7:31 AM - StreetInsider
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
May 4, 2026 7:30 AM - Globe NewsWire
Form DEFA14A MACROGENICS INC
April 22, 2026 4:45 PM - SEC Filing
MacroGenics (MGNX) PT Raised to $6 at Barclays
April 20, 2026 4:00 AM - StreetInsider
B.Riley Upgrades MacroGenics (MGNX) to Buy, 'uniquely situated'
April 10, 2026 6:58 AM - StreetInsider
Form 8-K MACROGENICS INC For: Apr 08
April 8, 2026 4:42 PM - SEC Filing
FDA lifts partial clinical hold on MacroGenics' cancer drug study
April 8, 2026 4:30 PM - StreetInsider
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
April 8, 2026 4:30 PM - StreetInsider
Form DEFA14A MACROGENICS INC
April 8, 2026 4:03 PM - SEC Filing
Form DEF 14A MACROGENICS INC For: May 19
April 8, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A MACROGENICS INC Filed by: VANGUARD GROUP INC
March 27, 2026 10:36 AM - SEC Filing
Stifel Reiterates Hold Rating on MacroGenics (MGNX): "MGC026 dose-escalation/expansion data should read well"
March 10, 2026 5:03 PM - StreetInsider
MacroGenics (MGNX) PT Raised to $4 at Barclays
March 10, 2026 4:24 AM - StreetInsider
Full Article List